Y. Chowers

Genetics · 2006–2017

A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Y. Chowers trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Stefan Schreiber (in Genetics)

Papers from Y. Chowers's perspective

Ordered by how strongly the researchers Y. Chowers trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease. (Clinical Gastroenterology and Hepatology)
  2. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. (Gastroenterology)
  3. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. (Gastroenterology)
  4. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. (Gastroenterology)
  5. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. (Gastroenterology)
  6. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. (Gastroenterology)
  7. Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee (American Journal of Gastroenterology)
  8. A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene (Science)
  9. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease (Nature Genetics)
  10. Placebo Effects: Biological, Clinical and Ethical Advances (The Lancet)

Their papers